Therefore, natural products or medications that can stimulate the intestinal receptor responsible for increasing the flux of apoB-lipoprotein derived cholesterol have the potential to open new preventative targets for hypercholesterolemia. This evidence concerns the gene APOB and familial hypercholesterolemia.